로딩 중…
지수 로딩 중…
Immatics N.V.
IMTX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
DE
DE$9.78+2.73%
2026-06-18
Price Chart
Immatics N.V.+67.18%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $1.34B |
| Revenue | $42M |
| Net Income | $-243M |
| Total Assets | $639M |
| Net Assets | $536M |
| Value | |
| P/B | 2.49x |
| P/S | 31.61x |
| FCF Yield | -15.99% |
| Profitability | |
| ROE | -45.36% |
| ROA | -38.05% |
| Op. Margin | -570.30% |
| Revenue Growth | -59.04% |
| Earnings Growth | -1390.89% |
| Financial Health | |
| Debt Ratio | 19.19% |
| Total Debt | $18M |
| FCF | $-214M |
| Cash | $354M |
| Current Ratio | 8.78x |
| Performance | |
| 1Y Return | 67.18% |
| 1M Return | -8.60% |
| From 52W High | -21.19% |
| 1Y MDD | -27.80% |
| Trading | |
| Volume | 330,101 shares |
| Trading Value | $3M |
| Per Share | |
| EPS | $-1.62 |
| BPS | $4.15 |